Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease. (June 2020)

• Record Type: Journal Article
• Authors: Bahrini, Khadija; Belghith, Meriam; Maghrebi, Olfa; Bekir, Jihène; Kchaou, Mariem; Jeridi, Cyrine; Amouri, Rim; Hentati, Faycel; Belal, Samir; Ben Sassi, Samia; Barbouche, Mohamed-Ridha
• Is Part Of: Cytokine. Volume 130(2020)
• Publication Date: 2020-06
• Subjects: Relapsing remitting multiple sclerosis -- Neuro-Behçet disease -- Cerebrospinal fluid -- CD39 -- CD73 -- IL-10; RRMS relapsing remitting multiple sclerosis -- NBD Neuro-Behçet disease -- NIND non inflammatory neurological disorders -- CNS central nervous system -- PBMCs peripheral blood mononuclear cells -- CSF cerebrospinal fluid -- CD39 E-NTPDase1 Ectonucleoside triphosphate diphosphohydrolase 1 -- CD73 Ecto-5′-Ntase, Ecto-5′-nucleotidase -- ATP adenosine triphosphate -- AMP adenosine monophosphate -- mRNA messenger RNA; Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2020.155054
• Languages: English
• ISSNs: 1043-4666

Abstract

Graphical abstract: Highlights: A higher CD39 mRNA expression in RRMS and NBD patients as compared to control group. A distinctive inflammatory microenvironment associated to an increase of TNF-α in RRMS CSF and IL-6 in NBD patients. Decrease level of CD73 mRNA expression in the CSF of NBD as compared to RRMS patients. In RRMS patients, a significant positive correlation of both CD39 and CD73 with IL-10 expression but not in NBD. CD39 is frequently expressed on Treg cells in RRMS patients and on B cells in NBD. Abstract: Treg‐mediated immune suppression involves many molecular mechanisms including the cleavage of inflammatory extracellular ATP to adenosine by CD39 ectoenzyme. In the peripheral blood of Multiple Sclerosis (MS) patients, it has been suggested that CD39+ Treg cells have the potential to suppress pro-inflammatory IL-17 secreting cells. Herein, we studied cellular phenotype and mRNA expression of CD39 and CD73 ectoenzymes in the Cerebrospinal fluid (CSF) of MS patients and another neuro-inflammatory disease: the Neuro-behçet's disease (NBD). Using qRT-PCR, we assessed mRNA expression of CD39 and CD73 as well as anti-inflammatory (IL-10) and pro-inflammatory (IL-6, TNF-α, IL-1β) cytokines in patients Peripheral blood mononuclear cells (PBMCs) and CSF of 28 relapsing-remitting multiple sclerosis (RRMS), 20 NBD and 22 controls with non inflammatory neurological disorders (NIND). The most substantial result in the CSF was the higher expression of CD39 in both RRMS and NBD patients compared to NIND. While, the expression of CD73 in CSF samples of NBD was low. In RRMS samples, we detected a significant positive correlation of both CD39 and CD73 with IL-10 expression. Moreover, results by flow cytometry revealed a high percentage of CD39 Treg cells in RRMS CSF. CD39 was preferentially expressed on B cells of NBD. Regarding inflammatory response, we showed a significant increase of IL-6 mRNA expression in NBD patients CSF while in RRMS this increase concerned TNF-α. These results bring evidence that CD39 correlates positively with an anti-inflammatory IL-10 response in RRMS. In contrast, no such association was observed in CSF of NBD patients and CD39 was preferentially expressed on B cells.